( AMEX:CRMD )

News from CorMedix Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 18, 2016, 08:30 ET CorMedix Inc. Presentation Now Available for On-Demand Viewing

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...


Jul 11, 2016, 08:30 ET CorMedix Inc. to Webcast, Live, at VirtualInvestorConferences.com July 14

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual...


Jan 21, 2016, 08:05 ET CorMedix to Present at National Kidney Foundation® 2016 Spring Clinical Meetings

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Jan 06, 2016, 08:30 ET CorMedix to Present at Biotech Showcase™ 2016

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Dec 14, 2015, 13:39 ET CorMedix Announces Enrollment and Dosing of First Patient in Phase 3 Neutrolin® Trial in Hemodialysis

 CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...


Jun 17, 2015, 08:53 ET CorMedix Inc. Receives Positive Feedback from FDA for Neutrolin® Clinical Trial Protocol for Oncology Patients

CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Mar 20, 2015, 08:00 ET CorMedix Announces Effectiveness of Registration Statements for Shares Underlying Publicly Traded Warrants

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Jan 29, 2015, 09:00 ET FDA Grants QIDP Designation to Neutrolin®, CorMedix Inc.'s Lead Product Candidate in the U.S.

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Jan 15, 2015, 10:34 ET CorMedix Inc. Receives Fast Track Designation for Neutrolin®

 CorMedix Inc. (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing...


Dec 23, 2014, 08:30 ET CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement in the Kingdom of Saudi Arabia

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Dec 04, 2014, 09:22 ET CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Dec 03, 2014, 14:09 ET Neutrolin Label Expansion Approved in Germany

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Nov 06, 2014, 16:08 ET CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...


Sep 25, 2014, 08:00 ET CorMedix Announces FDA IND Filing for Neutrolin® in United States

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Sep 22, 2014, 08:00 ET Neutrolin Label Expansion Approved for the European Union

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Sep 16, 2014, 08:00 ET CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...


Aug 14, 2014, 16:45 ET FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Jul 24, 2014, 12:30 ET CorMedix, Inc. Granted Extension of NYSE-MKT Listing

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Jun 23, 2014, 16:15 ET CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


May 23, 2014, 16:15 ET CorMedix Notified of NYSE MKT Listing Deficiency

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...


May 13, 2014, 17:26 ET CorMedix Inc. to Announce First Quarter 2014 Results on May 15, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic...


Apr 07, 2014, 08:30 ET CorMedix Inc. Welcomes Additional Board Members

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...


Mar 27, 2014, 18:39 ET CorMedix Inc. to Report 2013 Year End Results on March 31, 2014, and Host Conference Call at 9 am on April 1, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...


Jan 13, 2014, 08:30 ET CorMedix Expands Neutrolin® Sales with Middle East Distribution Agreements

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...


Jan 10, 2014, 08:32 ET CorMedix Awarded European Patent for Neutrolin

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...